Terms: = Brain cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
13 results:
1. Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
Stratmann JA; Althoff FC; Doebel P; Rauh J; Trummer A; Hünerlitürkoglu AN; Frost N; Yildirim H; Christopoulos P; Burkhard O; Büschenfelde CMZ; Becker von Rose A; Alt J; Aries SP; Webendörfer M; Kaldune S; Uhlenbruch M; Tritchkova G; Waller CF; Rittmeyer A; Hoffknecht P; Braess J; Kopp HG; Grohé C; Schäfer M; Schumann C; Griesinger F; Kuon J; Sebastian M; Reinmuth N
Eur J Cancer; 2024 Apr; 201():113911. PubMed ID: 38377774
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
4. Integrative Analysis of a Large Real-World Cohort of Small Cell Lung cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM
Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic and Genomic Landscape of Non-Small Cell Lung cancer brain Metastases.
Huang RSP; Harries L; Decker B; Hiemenz MC; Murugesan K; Creeden J; Tolba K; Stabile LP; Ramkissoon SH; Burns TF; Ross JS
Oncologist; 2022 Oct; 27(10):839-848. PubMed ID: 35598205
[TBL] [Abstract] [Full Text] [Related]
6. The protein kinase lkb1 promotes self-renewal and blocks invasiveness in glioblastoma.
Caja L; Dadras MS; Mezheyeuski A; Rodrigues-Junior DM; Liu S; Webb AT; Gomez-Puerto MC; Ten Dijke P; Heldin CH; Moustakas A
J Cell Physiol; 2022 Jan; 237(1):743-762. PubMed ID: 34350982
[TBL] [Abstract] [Full Text] [Related]
7. Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and stk11: A case report.
Fricke J; Mambetsariev I; Pharaon R; Subbiah S; Rajurkar S; Salgia R
Medicine (Baltimore); 2020 Nov; 99(46):e22323. PubMed ID: 33181636
[TBL] [Abstract] [Full Text] [Related]
8. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract] [Full Text] [Related]
9. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
Pepe F; Pisapia P; Del Basso de Caro ML; Conticelli F; Malapelle U; Troncone G; Martinez JC
Histol Histopathol; 2020 Jul; 35(7):741-749. PubMed ID: 31872418
[TBL] [Abstract] [Full Text] [Related]
10. Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer.
Chen GQ; Gong RH; Yang DJ; Zhang G; Lu AP; Yan SC; Lin SH; Bian ZX
Cell Death Dis; 2017 May; 8(5):e2789. PubMed ID: 28492544
[TBL] [Abstract] [Full Text] [Related]
11. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Olvedy M; Tisserand JC; Luciani F; Boeckx B; Wouters J; Lopez S; Rambow F; Aibar S; Thienpont B; Barra J; Köhler C; Radaelli E; Tartare-Deckert S; Aerts S; Dubreuil P; van den Oord JJ; Lambrechts D; De Sepulveda P; Marine JC
J Clin Invest; 2017 Jun; 127(6):2310-2325. PubMed ID: 28463229
[TBL] [Abstract] [Full Text] [Related]
12. Widely metastatic atypical pituitary adenoma with mTOR pathway stk11(F298L) mutation treated with everolimus therapy.
Donovan LE; Arnal AV; Wang SH; Odia Y
CNS Oncol; 2016 Oct; 5(4):203-9. PubMed ID: 27615706
[TBL] [Abstract] [Full Text] [Related]
13. Metformin: a modulator of bevacizumab activity in cancer? A case report.
Indraccolo S; Randon G; Zulato E; Nardin M; Aliberti C; Pomerri F; Casarin A; Nicoletto MO
Cancer Biol Ther; 2015; 16(2):210-4. PubMed ID: 25607951
[TBL] [Abstract] [Full Text] [Related]
